NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

DCTH

Delcath Systems Inc

May 16 • 04:00PM ET

17.10

Dollar change +1.05
Percentage change 6.54	%

Healthcare • Medical Devices • USA • NASD

Peers: MNOV CRMD BLRX PSTV HOOK CYCN AVGR SCPH TTOO

| Held by: VTI DWAS VXF SURI IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.51	Insider Own	11.96%	Shs Outstand	33.44M	Perf Week	15.23%
Market Cap	595.53M	Forward P/E	26.96	EPS next Y	0.63	Insider Trans	0.00%	Shs Float	30.66M	Perf Month	48.05%
Income	-14.21M	PEG	-	EPS next Q	0.01	Inst Own	40.68%	Short Float	3.27%	Perf Quarter	5.04%
Sales	53.85M	P/S	11.06	EPS this Y	101.54%	Inst Trans	40.01%	Short Ratio	2.19	Perf Half Y	76.29%
Book/sh	2.40	P/B	7.13	EPS next Y	4339.91%	ROA	-23.02%	Short Interest	1.00M	Perf Year	141.87%
Cash/sh	1.69	P/C	10.11	EPS next 5Y	-	ROE	-29.95%	52W Range	6.33 - 16.97	Perf YTD	42.03%
Dividend Est.	-	P/FCF	-	EPS past 5Y	69.36%	ROI	-17.51%	52W High	0.77%	Beta	0.94
Dividend TTM	-	Quick Ratio	14.61	Sales past 5Y	354.86%	Gross Margin	84.90%	52W Low	170.14%	ATR (14)	0.89
Dividend Ex-Date	-	Current Ratio	15.95	EPS Y/Y TTM	81.29%	Oper. Margin	-2.77%	RSI (14)	77.19	Volatility	5.90% 5.34%
Employees	96	Debt/Eq	0.01	Sales Y/Y TTM	1068.87%	Profit Margin	-26.38%	Recom	1.00	Target Price	23.57
Option/Short	Yes / Yes	LT Debt/Eq	0.01	EPS Q/Q	106.07%	Payout	-	Rel Volume	1.14	Prev Close	16.05
Sales Surprise	18.32%	EPS Surprise	40.19%	Sales Q/Q	530.26%	Earnings	May 08 BMO	Avg Volume	457.71K	Price	17.10
SMA20	30.07%	SMA50	34.90%	SMA200	47.26%	Trades		Volume	522,861	Change	6.54%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-28-24	Initiated	Craig Hallum	Buy	$18
May-14-24	Initiated	Stephens	Overweight	$25
Jul-26-22	Resumed	Canaccord Genuity	Buy	$17
Dec-10-21	Initiated	H.C. Wainwright	Buy	$25
Mar-09-21	Initiated	Canaccord Genuity	Buy	$24
Jan-05-21	Initiated	BTIG Research	Buy	$23
Jun-01-20	Initiated	Laidlaw	Buy	$19

May-15-25 04:30PM	Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference (Business Wire) +6.54%
May-09-25 05:30PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
03:15AM	Delcath Systems Inc (DCTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-25 08:45AM	Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates (Zacks) +23.64%
07:30AM	Delcath Systems Reports First Quarter 2025 Results and Business Highlights (Business Wire)
06:00PM	Loading…
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
02:21PM	Delcath Systems Q1 2025 Earnings Preview (Seeking Alpha)
May-06-25 07:10AM	Waters (WAT) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-28-25 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Breast Cancer (Business Wire)
Apr-27-25 09:22AM	Immunocore Holdings: A Name On My Watch List (Seeking Alpha)
Apr-24-25 04:01PM	Delcath Systems to Host First Quarter 2025 Earnings Call (Business Wire)
Apr-10-25 09:03AM	Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? (Zacks) -7.71%
Apr-09-25 05:00PM	Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma (Business Wire) +9.82%
Apr-02-25 11:49AM	Hospitals Experience FOMO In Adopting Delcath's PHP Treatment (Seeking Alpha)
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
10:46AM	Loading…
10:46AM	Jim Cramer Blesses Delcath Systems (DCTH): 'You're Not Early, But It's a Win' (InsiderMonkey)
Mar-26-25 09:55AM	Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? (Zacks) -6.52%
Mar-24-25 04:01PM	Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire)
Mar-19-25 09:40AM	Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-14-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-06-25 08:00AM	Delcath Systems Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-20-25 08:30AM	Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call (Business Wire)
Feb-14-25 08:30AM	Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma (Business Wire)
Jan-31-25 07:00AM	Biotech walks a 'tightrope' amid unclear funding, regulations (Yahoo Finance Video)
Jan-28-25 04:01PM	Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Jan-15-25 02:31PM	Delcath Systems, Inc. (DCTH): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey)
Jan-13-25 08:00AM	Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results (Business Wire) +11.41%
Jan-03-25 04:01PM	Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-30-24 08:00AM	Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises (Business Wire)
Dec-02-24 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer (Business Wire) +6.40%
04:00PM	Loading…
Nov-09-24 04:00PM	Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-08-24 08:00AM	Delcath Systems Reports Third Quarter 2024 Results and Business Highlights (Business Wire)
Nov-01-24 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-24 08:30AM	Delcath Systems to Host Third Quarter 2024 Earnings Call (Business Wire)
Oct-17-24 08:30AM	Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results (Business Wire) +7.57%
Sep-20-24 04:01PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-16-24 08:30AM	Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT in Metastatic Uveal Melanoma Subgroups (Business Wire)
Aug-28-24 04:01PM	Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients (Business Wire)
04:01PM	Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire)
Aug-27-24 08:30AM	Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients (Business Wire) +15.57%
Aug-26-24 04:01PM	Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors (Business Wire) +13.86%
Aug-20-24 08:30AM	Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress (Business Wire)
Aug-12-24 04:01PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-05-24 08:59PM	DCTH Stock Earnings: Delcath Systems Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace)
04:01PM	Delcath Systems Reports Second Quarter 2024 Results and Business Highlights (Business Wire)
08:30AM	Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT (Business Wire)
Jul-30-24 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Jul-22-24 04:01PM	Delcath Systems to Host Second Quarter 2024 Earnings Call (Business Wire)
Jul-15-24 12:00PM	Delcath Systems, Inc. (DCTH) is a Great Momentum Stock: Should You Buy? (Zacks)
Jun-14-24 08:50AM	Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength (Zacks)
Jun-03-24 09:55AM	Does Delcath Systems (DCTH) Have the Potential to Rally 197.87% as Wall Street Analysts Expect? (Zacks)
May-28-24 09:30AM	Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors (Business Wire) -5.53%
May-17-24 09:55AM	Wall Street Analysts Predict a 201.72% Upside in Delcath Systems (DCTH): Here's What You Should Know (Zacks) +8.76%
May-15-24 08:50AM	What Makes Delcath Systems (DCTH) a Good Fit for 'Trend Investing' (Zacks)
03:02AM	Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ... (GuruFocus.com)
May-14-24 11:52AM	DCTH Stock Earnings: Delcath Systems Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +30.93%
07:30AM	Delcath Systems Reports First Quarter 2024 Results and Business Highlights (PR Newswire)
May-07-24 08:30AM	Delcath Systems to Host First Quarter 2024 Earnings Call (PR Newswire)
May-06-24 09:00AM	Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT (PR Newswire)
May-03-24 05:15PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Apr-23-24 09:55AM	How Much Upside is Left in Delcath Systems (DCTH)? Wall Street Analysts Think 244.83% (Zacks)
Apr-05-24 09:55AM	Can Delcath Systems (DCTH) Climb 277.73% to Reach the Level Wall Street Analysts Expect? (Zacks)
Apr-04-24 08:35AM	Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Apr-02-24 12:00PM	Delcath Systems (DCTH) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-27-24 11:50AM	Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2023 Earnings Call Transcript (Insider Monkey) +10.41%
Mar-26-24 11:52AM	DCTH Stock Earnings: Delcath Systems Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
09:12AM	Delcath Systems Inc (DCTH) Reports Mixed Year-End Financials Amidst Strategic Advancements (GuruFocus.com)
08:40AM	Delcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (PR Newswire)
Mar-22-24 02:43PM	Hedge Fund and Insider Trading News: David Tepper, Ken Griffin, Starboard Value, ExodusPoint Capital, Elliott Management, Three Arrows Capital, Delcath Systems Inc (DCTH), Dell Technologies Inc (DELL), and More (Insider Monkey)
Mar-20-24 08:15AM	Delcath Systems Closes $7 Million Private Placement (PR Newswire)
Mar-19-24 09:00AM	Delcath Systems to Host Fourth Quarter and Full Year 2023 Results and Business Update Call (PR Newswire)
Mar-18-24 05:20PM	Delcath Systems Appoints Martha S. Rook as Chief Operating Officer (PR Newswire) +5.29%
Mar-15-24 08:20AM	Delcath Systems Announces $7 Million Private Placement (PR Newswire) +6.72%
Mar-08-24 05:00PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
09:00AM	Delcath Systems to Participate in Upcoming Investor Conferences (PR Newswire)
Feb-22-24 05:00PM	Delcath Systems Announces Healthcare Setting Locator for HEPZATO KIT (melphalan/Hepatic Delivery System) (PR Newswire)
Feb-16-24 05:00PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Jan-31-24 08:00AM	Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO (melphalan/Hepatic Delivery System) Effective April 1, 2024 (PR Newswire) +7.88%
Jan-23-24 08:00AM	Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference (PR Newswire)
Jan-16-24 08:00AM	Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT (PR Newswire)
Jan-12-24 05:00PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Dec-15-23 01:02PM	Insider Buying: Chief Medical Officer Vojo Vukovic Acquires 40,000 Shares of Delcath Systems ... (GuruFocus.com)
Dec-07-23 09:00AM	Delcath Systems Announces Publication by Independent Investigators of a Retrospective Analysis of Quality of Life in the Journal Melanoma Research (PR Newswire)
Nov-15-23 05:00PM	Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Nov-13-23 04:05PM	Delcath Systems Reports Third Quarter 2023 Results and Provides Business Update (PR Newswire) -24.50%
Nov-06-23 04:30PM	Delcath Systems to Host Third Quarter 2023 Results Call (PR Newswire)
Oct-16-23 08:30AM	Delcath Systems Announces a Comparative Study of Chemosat and SIRT Published in the Journal Cancers (PR Newswire) +6.07%
Oct-10-23 08:30AM	Delcath Systems to Participate in the Lytham Partners Fall 2023 Investor Conference (PR Newswire)
Oct-03-23 08:30AM	Delcath Systems to Participate at the Roth MKM 2023 Healthcare Opportunities Conference on October 12, 2023 (PR Newswire)
Sep-27-23 04:05PM	Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Sep-14-23 09:59AM	These 2 Strong Buy Penny Stocks Could Soar to $17 (Or Higher), Say Analysts (TipRanks)
Sep-11-23 08:00AM	A Retrospective Comparative Study of Chemosat and SIRT Presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting (PR Newswire)
Sep-05-23 04:00PM	Delcath Systems to Participate at the H.C. Wainwright 25th Annual Investor Conference on September 12 and 13, 2023 (PR Newswire)
Sep-01-23 02:07PM	Delcath Systems, Inc. Announces Additional $35 Million in Funding Tied to the FDA Approval of HEPZATO KIT (PR Newswire) +5.88%
Aug-29-23 08:00AM	Delcath Systems Announces an Independent Investigator Presentation at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Annual Meeting (PR Newswire)
Aug-14-23 09:10PM	Delcath Systems, Inc. Announces FDA Approval of HEPZATO KIT for the Treatment of Adult Patients with Unresectable Hepatic-Dominant Metastatic Uveal Melanoma (PR Newswire) +81.73%
Aug-12-23 09:02AM	Delcath Systems, Inc.'s (NASDAQ:DCTH) Path To Profitability (Simply Wall St.)
Aug-09-23 05:33PM	Delcath Systems Reports Second Quarter 2023 Results and Provides Business Update (PR Newswire) -16.54%
Aug-03-23 08:30AM	Delcath Systems to File Its Second Quarter 2023 10-Q the Week of August 7 and Expects to Host a Conference Call the Following Week (PR Newswire)

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MICHEL GERARD J	CHIEF EXECUTIVE OFFICER	Oct 22 '24	Option Exercise	6.00	16,666	99,996	319,334	Oct 23 04:17 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DCTH

Delcath Systems Inc

Upgrade your FINVIZ experience